Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers

Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive

ClinicalTrials.gov ID: NCT00362479

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00362479. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:13 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of the 28-Day Oral Contraceptive DR-1021

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open-label, single treatment study. All subjects will receive 6 months of oral contraceptive therapy with DR-1021. Study participants will receive physical and gynecological exams, including Pap smear. During the study, all participants will be required to complete a diary.

Study identification

NCT ID
NCT00362479
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Duramed Research
Industry
Enrollment
1,347 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2006 (Type not available)
Primary completion
Jul 2007 (Actual)
Completion
Jul 2007 (Actual)
Last update posted
Aug 21, 2013

2006 – 2007

United States locations

U.S. sites
85
U.S. states
30
U.S. cities
79
Facility City State ZIP Site status
Duramed Investigational Site Huntsville Alabama 35801 —
Duramed Investigational Site Mobile Alabama 36608 —
Duramed Investigational Site Phoenix Arizona 85015 —
Duramed Investigational Site Phoenix Arizona 85031 —
Duramed Investigational Site Carmichael California 95608 —
Duramed Investigational Site Irvine California 92618 —
Duramed Investigational Site San Diego California 92108 —
Duramed Investigational Site San Diego California 92123 —
Duramed Investigational Site San Ramon California 94583 —
Duramed Investigational Site Colorado Springs Colorado 80909 —
Duramed Investigational Site Lakewood Colorado 80228 —
Duramed Investigational Site Wilmington Delaware 19805 —
Duramed Investigational Site Washington D.C. District of Columbia 20006 —
Duramed Investigational Site Aventura Florida 33180 —
Duramed Investigational Site Boynton Beach Florida 33437 —
Duramed Investigational Site Brooksville Florida 33613 —
Duramed Investigational Site Clearwater Florida 33761 —
Duramed Investigational Site Coral Gables Florida 33134 —
Duramed Investigational Site Fort Meyers Florida 33918 —
Duramed Investigational Site Leesburg Florida 34748 —
Duramed Investigational Site Longwood Florida 32779 —
Duramed Investigational Site Miami Florida 33173 —
Duramed Investigational Site Pinellas Park Florida 33781 —
Duramed Investigational Site Sarasota Florida 34239 —
Duramed Investigational Site St. Petersburg Florida 33702 —
Duramed Investigational Site St. Petersburg Florida 33709 —
Duramed Investigational Site Tampa Florida 33613 —
Duramed Investigational Site West Palm Beach Florida 33409 —
Duramed Investigational Site Atlanta Georgia 30328 —
Duramed Investigational Site Atlanta Georgia 30342 —
Duramed Investigational Site Decatur Georgia 30034 —
Duramed Investigational Site Roswell Georgia 30075 —
Duramed Investigational Site Boise Idaho 83704 —
Duramed Investigational Site Chicago Illinois 60611 —
Duramed Investigational Site Chicago Illinois 60612 —
Duramed Investigational Site Peoria Illinois 61602 —
Duramed Investigational Site Shawnee Mission Kansas 66216 —
Duramed Investigational Site Topeka Kansas 66614 —
Duramed Investigational Site Lexington Kentucky 40509 —
Duramed Investigational Site Louisville Kentucky 40291 —
Duramed Investigational Site Mount Sterling Kentucky 40353 —
Duramed Investigational Site Kansas City Missouri 64108 —
Duramed Investigational Site Lincoln Nebraska 68510 —
Duramed Investigational Site Las Vegas Nevada 89146 —
Duramed Investigational Site Moorestown New Jersey 08057 —
Duramed Investigational Site New Brunswick New Jersey 08901 —
Duramed Investigational Site Albuquerque New Mexico 87102 —
Duramed Investigational Site Johnson City New York 13790 —
Duramed Investigational Site Rochester New York 14609 —
Duramed Investigational Site Charlotte North Carolina 28211 —
Duramed Investigational Site Raleigh North Carolina 27612 —
Duramed Investigational Site Wilmington North Carolina 28412 —
Duramed Investigational Site Winston-Salem North Carolina 27103 —
Duramed Investigational Site Columbus Ohio 43210 —
Duramed Investigational Site Columbus Ohio 43213 —
Duramed Investigational Site Oklahoma City Oklahoma 73112 —
Duramed Investigational Site Medford Oregon 97504 —
Duramed Investigational Site Philadelphia Pennsylvania 19114 —
Duramed Investigational Site Reading Pennsylvania 19606 —
Duramed Investigational Site Cranston Rhode Island 02920 —
Duramed Investigational Site Greer South Carolina 29651 —
Duramed Investigational Site Mt. Pleasant South Carolina 29464 —
Duramed Investigational Site Bristol Tennessee 37620 —
Duramed Investigational Site Chattanooga Tennessee 37404 —
Duramed Investigational Site Clarksville Tennessee 37043 —
Duramed Investigational Site Germantown Tennessee 38138 —
Duramed Investigational Site Knoxville Tennessee 37920 —
Duramed Investigational Site Nashville Tennessee 37203 —
Duramed Investigational Site Austin Texas 78759 —
Duramed Investigational Site Dallas Texas 75234 —
Duramed Investigational Site Houston Texas 77030 —
Duramed Investigational Site San Antonio Texas 78229 —
Duramed Investigational Site Waco Texas 76712 —
Duramed Investigational Site Magna Utah 84044 —
Duramed Investigational Site Pleasant Grove Utah 84062 —
Duramed Investigational Site Salt Lake City Utah 84124 —
Duramed Investigational Site Sandy City Utah 84070 —
Duramed Investigational Site Arlington Virginia 22203 —
Duramed Investigational Site Newport News Virginia 23602 —
Duramed Investigational Site Norfolk Virginia 23507 —
Duramed Investigational Site Richmond Virginia 23233 —
Duramed Investigational Site Lakewood Washington 98499 —
Duramed Investigational Site Seattle Washington 98105 —
Duramed Investigational Site Spokane Washington 99207 —
Duramed Investigational Site Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00362479, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 21, 2013 · Synced Nov 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.